These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 778274)
1. Preparation of conjugated erythrocytes for long term use in hemolytic plaque assays, complement fixation studies, or passive hemagglutinations: a comparative study of several methods. Habicht GS; Miller F J Immunol Methods; 1976; 11(2):117-27. PubMed ID: 778274 [TBL] [Abstract][Full Text] [Related]
2. Succinylation of hapten-protein conjugates facilitates coupling to erythrocytes by water soluble carbodiimide: preparation of stable and sensitive target cells for use in hemolytic assays. Jou YH; Johnson G; Pressman D J Immunol Methods; 1981; 42(1):79-92. PubMed ID: 7017001 [TBL] [Abstract][Full Text] [Related]
3. Use of dextran-conjugated SRBC for the detection of MOPC 104E tumor cells. Ghanta VK; Hamlin NM; Pretlow TG; Hiramoto RN J Immunol; 1972 Oct; 109(4):810-5. PubMed ID: 4561473 [No Abstract] [Full Text] [Related]
4. Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration. Schmid FR; Roitt IM; Rocha MJ J Exp Med; 1970 Oct; 132(4):673-93. PubMed ID: 5508376 [TBL] [Abstract][Full Text] [Related]
5. Preparation of functionalized derivatives of inulin: conjugation of erythrocytes for hemagglutination and plaque-forming cell assays. Chien CC; Lieberman R; Inman JK J Immunol Methods; 1979; 26(1):39-46. PubMed ID: 374632 [TBL] [Abstract][Full Text] [Related]
6. Preparation of dinitrofluorobenzene-treated sheep erythrocytes for detection of anti-DNP plaque-forming cells. Trump GN J Immunol; 1972 Oct; 109(4):754-60. PubMed ID: 4116358 [No Abstract] [Full Text] [Related]
7. Complement fixation by rheumatoid factor. Tanimoto K; Cooper NR; Johnson JS; Vaughan JH J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825 [TBL] [Abstract][Full Text] [Related]
8. Coupling of large haptens to proteins and cell surfaces: preparation of stable, optimally sensitized erythrocytes for hapten-specific, hemolytic plaque assays. Inman JK; Merchant B; Claflin L; Tacey SE Immunochemistry; 1973 Mar; 10(3):165-74. PubMed ID: 4591829 [No Abstract] [Full Text] [Related]
9. Comparison of three hemolytic plaque assays using sheep and mouse erythrocytes as antigens in rats. Peterman GM; Wust CJ Proc Soc Exp Biol Med; 1975 Nov; 150(2):289-94. PubMed ID: 1108037 [TBL] [Abstract][Full Text] [Related]
10. Use of erythrocytes sensitized with purified enterotoxin from Vibrio cholerae for the assay of antibody and antibody-forming cells. Kateley JR; Friedman H J Infect Dis; 1975 Feb; 131(2):144-8. PubMed ID: 1090686 [TBL] [Abstract][Full Text] [Related]
12. Antibody-binding characteristics at the cellular level. I. Comparative maturation of hapten-specific IgM and IgG plaque-forming cell populations. Claflin L; Merchant B; Inman J J Immunol; 1973 Jan; 110(1):241-51. PubMed ID: 4568183 [No Abstract] [Full Text] [Related]
13. Regulation of the immune response. IV. Antibody-mediated suppression of the immune response to haptens and heterologous erythrocyte antigens in vitro. Kappler JW; van der Hoven A; Dharmarajan U; Hoffmann M J Immunol; 1973 Oct; 111(4):1228-35. PubMed ID: 4580667 [No Abstract] [Full Text] [Related]
14. [Passive hemagglutination reaction in differentiating foot-and-mouth disease viruses]. Tekerlekov P; Veleva E Vet Med Nauki; 1983; 20(3-4):7-13. PubMed ID: 6312672 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of a lipopolysaccharide designed to conjugate haptens and proteins to erythrocyte for use as target cells in passive hemagglutination and hemolytic assays. Bankert RB; Mayers GL; Pressman D J Immunol; 1979 Dec; 123(6):2466-74. PubMed ID: 387871 [No Abstract] [Full Text] [Related]
17. [The use of CrCl 3 for coupling of foot-and-mouth disease virus to erythrocytes, and the ability of these sensitized erythrocytes to react in passive hemagglutination (PHA) and passive immunohemolysis (PIH)]. Reda IM; Wittmann G Arch Gesamte Virusforsch; 1972; 38(2):205-15. PubMed ID: 4352304 [No Abstract] [Full Text] [Related]
18. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. Schreiber AD; Frank MM J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104 [TBL] [Abstract][Full Text] [Related]
19. Antibody coating of liposomes with 1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide and the effect on target specificity. Endoh H; Suzuki Y; Hashimoto Y J Immunol Methods; 1981; 44(1):79-85. PubMed ID: 7252176 [TBL] [Abstract][Full Text] [Related]
20. Immunology of the lower respiratory tract. II. The plaque-forming response of canine lymphoid tissues to sheep erythrocytes after intrapulmonary or intravenous immunization. Kaltreider HB; Kyselka L; Salmon SE J Clin Invest; 1974 Aug; 54(2):263-70. PubMed ID: 4603168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]